tiprankstipranks
Trending News
More News >
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market
Advertisement

STRATEC Biomedical (SBS) Ratios

Compare
4 Followers

STRATEC Biomedical Ratios

DE:SBS's free cash flow for Q2 2025 was €0.27. For the 2025 fiscal year, DE:SBS's free cash flow was decreased by € and operating cash flow was €0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.02 2.57 3.51 4.12 4.38
Quick Ratio
1.15 1.09 1.56 2.17 2.47
Cash Ratio
0.28 0.35 0.38 1.03 1.05
Solvency Ratio
0.18 0.14 0.27 0.35 0.27
Operating Cash Flow Ratio
0.38 0.20 0.17 1.39 0.89
Short-Term Operating Cash Flow Coverage
0.78 0.44 2.09 13.47 9.45
Net Current Asset Value
€ 16.36M€ 14.72M€ 39.07M€ 25.25M€ -3.08M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.30 0.22 0.23 0.33
Debt-to-Equity Ratio
0.54 0.61 0.39 0.41 0.64
Debt-to-Capital Ratio
0.35 0.38 0.28 0.29 0.39
Long-Term Debt-to-Capital Ratio
0.29 0.26 0.23 0.26 0.36
Financial Leverage Ratio
1.78 2.00 1.77 1.79 1.92
Debt Service Coverage Ratio
1.10 0.77 6.98 9.53 10.71
Interest Coverage Ratio
9.82 7.30 22.01 35.49 29.19
Debt to Market Cap
0.34 0.23 0.07 0.05 0.07
Interest Debt Per Share
10.61 11.96 7.34 7.16 9.18
Net Debt to EBITDA
2.44 2.50 1.12 0.58 1.37
Profitability Margins
Gross Profit Margin
30.32%24.76%28.94%30.53%27.58%
EBIT Margin
10.08%9.75%14.92%16.80%13.65%
EBITDA Margin
17.53%16.48%20.95%22.78%21.03%
Operating Profit Margin
10.69%11.13%15.21%17.67%12.99%
Pretax Profit Margin
7.90%8.23%14.23%16.30%13.20%
Net Profit Margin
5.72%5.87%10.64%13.91%10.07%
Continuous Operations Profit Margin
5.72%5.87%10.64%13.91%11.37%
Net Income Per EBT
72.38%71.34%74.76%85.32%76.24%
EBT Per EBIT
73.88%73.93%93.55%92.22%101.65%
Return on Assets (ROA)
3.48%3.29%7.35%10.84%7.59%
Return on Equity (ROE)
6.23%6.59%12.98%19.42%14.59%
Return on Capital Employed (ROCE)
7.73%7.87%12.39%15.73%10.97%
Return on Invested Capital (ROIC)
5.12%4.80%9.07%13.15%9.28%
Return on Tangible Assets
4.75%4.35%9.45%14.31%10.35%
Earnings Yield
3.78%2.78%2.97%2.39%1.70%
Efficiency Ratios
Receivables Turnover
5.55 4.32 4.75 6.97 6.59
Payables Turnover
12.15 9.19 17.96 17.51 21.34
Inventory Turnover
1.43 1.38 1.66 2.25 2.66
Fixed Asset Turnover
3.27 3.12 3.71 4.26 3.82
Asset Turnover
0.61 0.56 0.69 0.78 0.75
Working Capital Turnover Ratio
1.90 1.73 1.87 2.19 2.34
Cash Conversion Cycle
290.63 308.95 276.58 193.84 175.34
Days of Sales Outstanding
65.79 84.52 76.88 52.38 55.35
Days of Inventory Outstanding
254.87 264.17 220.03 162.31 137.09
Days of Payables Outstanding
30.03 39.74 20.32 20.85 17.10
Operating Cycle
320.66 348.69 296.91 214.69 192.44
Cash Flow Ratios
Operating Cash Flow Per Share
2.06 1.60 0.85 5.24 2.64
Free Cash Flow Per Share
0.89 0.16 -0.72 3.57 0.52
CapEx Per Share
1.18 1.43 1.57 1.67 2.12
Free Cash Flow to Operating Cash Flow
0.43 0.10 -0.85 0.68 0.20
Dividend Paid and CapEx Coverage Ratio
1.17 0.66 0.34 2.04 0.89
Capital Expenditure Coverage Ratio
1.75 1.11 0.54 3.14 1.25
Operating Cash Flow Coverage Ratio
0.20 0.14 0.12 0.74 0.29
Operating Cash Flow to Sales Ratio
0.10 0.07 0.04 0.22 0.13
Free Cash Flow Yield
2.88%0.36%-0.89%2.59%0.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.42 36.03 33.67 41.77 58.84
Price-to-Sales (P/S) Ratio
1.48 2.11 3.58 5.81 5.92
Price-to-Book (P/B) Ratio
1.64 2.37 4.37 8.11 8.58
Price-to-Free Cash Flow (P/FCF) Ratio
34.72 276.71 -112.57 38.60 236.31
Price-to-Operating Cash Flow Ratio
15.20 28.50 95.72 26.29 46.51
Price-to-Earnings Growth (PEG) Ratio
-2.06 -0.75 -1.25 1.15 0.73
Price-to-Fair Value
1.64 2.37 4.37 8.11 8.58
Enterprise Value Multiple
10.89 15.33 18.22 26.08 29.54
Enterprise Value
491.09M 661.54M 1.05B 1.71B 1.55B
EV to EBITDA
10.89 15.33 18.22 26.08 29.54
EV to Sales
1.91 2.53 3.82 5.94 6.21
EV to Free Cash Flow
44.74 330.61 -119.95 39.48 247.80
EV to Operating Cash Flow
19.21 34.06 101.99 26.89 48.77
Tangible Book Value Per Share
10.00 9.87 11.29 9.61 6.96
Shareholders’ Equity Per Share
19.10 19.19 18.56 16.99 14.31
Tax and Other Ratios
Effective Tax Rate
0.28 0.29 0.25 0.15 0.14
Revenue Per Share
20.75 21.55 22.64 23.73 20.73
Net Income Per Share
1.19 1.26 2.41 3.30 2.09
Tax Burden
0.72 0.71 0.75 0.85 0.76
Interest Burden
0.78 0.84 0.95 0.97 0.97
Research & Development to Revenue
0.04 0.03 0.03 0.03 0.03
SG&A to Revenue
0.10 0.07 0.07 0.06 0.08
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 0.02
Income Quality
1.74 1.49 0.35 1.59 1.27
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis